About us
Our company
C4Diagnostics is a French-based biotech founded in 2017 and specialized in the development of in vitro diagnostic (IVD) tests for human infectious diseases.
Our company is ISO 13485 certified.
Our proprietary Click-chemistry technology is at the core of our portfolio of rapid diagnostic tests, which currently focuses on the diagnosis Legionnaires’ Disease (C4Legio LFA), urinary tract infections (C4UTI) and the development of antimicrobial susceptibility tests (C4AST).
Since 2021, through our business unit C4Environment, we develop and offer environmental testing solutions for companies, institutions and healthcare facilities. These solutions enable the detection of pathogens (viruses, bacteria, molds and yeasts) from environment samples (air, wastewater and surfaces).
Our vision
We believe that rapid and reliable diagnostic tools are game changing in the way infectious diseases are handled, lead to better patient care, and bring a powerful leverage to fight antimicrobial resistance.
We are committed to bringing reliable and actionable diagnostic information to healthcare professionals in a timely manner.
Our values
More than just words, those values are shared amongst C4Diagnostics team members and partners.
Patient Care
We believe infectious diseases can be managed differently. Every day we strive to improve patient care and save lives.
We are committed to provide healthcare professionals with rapid, reliable and highly sensitive diagnostic solutions, as well as ready-to-use and user-friendly.
We are able to meet tight deadlines and pivot if need be, as shown with the Covid-19 pandemic.
Team spirit
At C4Diagnostics, we believe that two heads are better than one, three are better than two… We move forward and grow collectively and individually by collaborating together.
Different by background, age, or experience, our employees are one of our greatest assets.
We all share the same mantra : succeeding as a team.
Business agility and commitment
When we cope with difficulties, hardships, unexpected events, far from giving up, we bounce back and adapt quickly offering alternatives.
For example, from the start of the Covid-19 crisis, we were among the first to step up by offering Covid-19 testing solutions, without neglecting our initial roadmap.
It reflects our agility and versatility.
History
C4Diagnostics was founded from an observation. In the diagnostic, there are fast solutions but not very sensitive, or very sensitive solutions but with a long delay for the results. We succeeded in combining the two. This is our company’s signature.
Our main milestones
Company creation
C4Diagnostics was founded in Marseille in May 2017 by Younes Lazrak, Emilie Fugier and Sam Dukan.
Series A fundraising of € 2,5 M
C4Diagnostics raises € 2.5 Million and brings a US investor to the founding round, to accelerate the deployment of its infectious diseases’ diagnostic solutions
Market-stage company
C4Covid-19 Human, our salivary test for the rapid diagnostic of Covid-19 is CE marked since March 2021. This is our first in vitro diagnostic product CE marked and on the market for a medical use.
Deployment of C4Environment
C4Diagnostics launches C4Environment, a comprehensive range of environmental testing solutions, to detect pathogens for private and public companies and healthcare facilities.
People
The C4Diagnostics management team is made up of experts in medical diagnostics, R&D, Regulatory affairs, Quality, Marketing and Sales.
Management team
Younes Lazrak, MBA, MSc
CEO & Cofounder
Younes worked in Business Development and IP management in several IVD companies (Incl. Ipsogen & Qiagen). His main responsibilities were Licensing in & out and the management of the industrial intellectual ownership, before progressively shifting to Business development and alliances management. He founded C4Diagnostics in May 2017 with Emilie Fugier and Sam Dukan.
Émilie Fugier, PhD
Head of R&D & Cofounder
After a PhD in microbiology and immunology, Emilie has managed various scientific projects involving pathogenic organisms with industries and hospitals. In 2012, she joined Sam Dukan's team in the CNRS to work on the technology used by C4Diagnostics. As Head of R&D, she's managing the scientific projects of the company.
Dhikra Feki, PharmD
Head of Quality, Regulatory Affairs & Market Access
After a Pharm.D degree and a Master degree in regulatory affairs, Dhikra has managed the RA for local market within different manufacturing companies. She was implementing registration strategies and advising on legal and scientific requirements. In july 2021, she joined C4Diagnostics as Head of Quality, Regulatory Affairs and Market Access.
Guillaume Tournier
Head of Finance & Accounting
With a Master degree in Controlling, Guillaume has more than 15 years of experience in Finance functions, notably in corporate financial management. In July 2021, he joined the company as Head of Finance and Accounting to make the company's financial information reliable and secure.
Strategic board
Younes LAZRAK
Chairman of the board / CEO
IVD – 20+ years exp.
Emilie Fugier
R&D – 17+ years exp.
Pierre CHAVAGNE
Finance / IVD – 22+ years exp.
General Manager (Cisbio Bioassays)
Sandra DUBOS
Business Strategy & Finance – 16+ years exp.
Head of Participations (Kreaxi)
Jean-François GRENIER
Strategy advisor & Market Access – 27+ years exp.
Angels santé
Hélène PEYRO-ST-PAUL
Medical Affairs – 22+ years exp.
Independant (former Qiagen, EMD Serono)
Marguerite PAPPALARDO
Finance – 20+ years exp.
Investment Director (Smalt Capital)
Andrei POLUKHTIN
Chemistry and Business owner – 17+ years exp.
Founder & Managing Director (Click Chemistry Tools)
Armand PERRIN
FInance – 32+ years exp.
Investment Manager (CAAP Création)